Management and Surveillance of Patients with MEN1 and MEN2

MEET-THE-EXPERTS SESSION III

Management and Surveillance of Patients with MEN1 and MEN2

4/27/2019
4:45 PM - 5:45 PM
Location: Convention Center 515 A

Robert F. Gagel, MD

Professor
MD Anderson Cancer Center

Robert Gagel, M.D. is a Professor of Medicine at MD Anderson Cancer Center where he served as Head of Endocrine Neoplasia and Head of Internal Medicine. He is a graduate of Ohio State University College of Medicine, did clinical training in Internal Medicine and Endocrinology and Metabolism at Tufts-New England Medical Center and a postdoctoral research fellowship at Harvard Medical School. He has been a faculty member at Baylor College of Medicine and MD Anderson Cancer Center. His major research accomplishments include a leadership role in the management of multiple endocrine neoplasia types 1 and 2, elucidation of the pathways by which mutations of the RET proto-oncogene cause medullary thyroid carcinoma and development of therapies based on this information, definition of the physiologic role of calcitonin and identification of mutations of the sulfonylurea receptor as the cause of persistent hypoglycemia of infancy.

Presentation(s):

Send Email for Robert Gagel

Sina Jasim, MD. MPH

Assistant Professor
Washington University

Dr Jasim completed her Endocrine fellowship at the Mayo clinic in Rochester, MN and She is currently an Assistant professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University in St. Louis School of Medicine. She is running the thyroid clinic and Endocrine neoplasia with focus on Thyroid cancer, MEN syndromes and Adrenal tumors

Presentation(s):

Send Email for Sina Jasim


Assets

Management and Surveillance of Patients with MEN1 and MEN2

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Management and Surveillance of Patients with MEN1 and MEN2